KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oscar Health (OSCR) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to 19.6%.

  • Oscar Health's EBITDA Margin fell 187900.0% to 19.6% in Q4 2025 from the same period last year, while for Dec 2025 it was 5.23%, marking a year-over-year decrease of 83300.0%. This contributed to the annual value of 3.39% for FY2025, which is 54100.0% down from last year.
  • Oscar Health's EBITDA Margin amounted to 19.6% in Q4 2025, which was down 187900.0% from 4.33% recorded in Q3 2025.
  • Over the past 5 years, Oscar Health's EBITDA Margin peaked at 9.75% during Q1 2025, and registered a low of 47.68% during Q3 2021.
  • Moreover, its 5-year median value for EBITDA Margin was 7.55% (2022), whereas its average is 10.54%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first surged by 915700bps in 2021, then plummeted by -187900bps in 2025.
  • Quarter analysis of 5 years shows Oscar Health's EBITDA Margin stood at 39.56% in 2021, then skyrocketed by 43bps to 22.36% in 2022, then dropped by -11bps to 24.83% in 2023, then soared by 97bps to 0.81% in 2024, then plummeted by -2333bps to 19.6% in 2025.
  • Its EBITDA Margin was 19.6% in Q4 2025, compared to 4.33% in Q3 2025 and 8.05% in Q2 2025.